Skip to content

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

August 27, 2025

New Releases from NCBI BookshelfEmergency Medical Services Streaming Enabled Evaluation In Trauma: The SEE-IT Feasibility RCT [Internet].Emergency Medical Services Streaming Enabled Evaluation In Trauma: The SEE-IT Feasibility RCT [Internet].

Leave a Comment / Uncategorized / admin

Some text in this abstract and article has been reproduced from Taylor et al. (Taylor C, Ollis L, Lyon RM, […]

New Releases from NCBI BookshelfMeeting the needs of women in the perinatal period, who use or are in treatment for using drugs: A mixed-methods systematic review [Internet].Meeting the needs of women in the perinatal period, who use or are in treatment for using drugs: A mixed-methods systematic review [Internet].

Leave a Comment / Uncategorized / admin

Women who use and/or are in treatment for using drugs during the perinatal period have complex health and social care

New Releases from NCBI BookshelfDupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal).Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAnti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis [Internet].Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis [Internet].

Leave a Comment / Uncategorized / admin

Diabetic retinopathy is a major cause of sight loss in people with diabetes. The most severe form, proliferative diabetic retinopathy,

New Releases from NCBI BookshelfPolatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma.Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfEculizumab for treating relapsing neuromyelitis optica (terminated appraisal).Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfNivolumab for advanced squamous non-small-cell lung cancer after chemotherapy.Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfSputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT [Internet].Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT [Internet].

Leave a Comment / Uncategorized / admin

Chronic obstructive pulmonary disease exacerbations (acute exacerbation of chronic obstructive pulmonary disease) are characterised by increased sputum volume, purulence and

New Releases from NCBI BookshelfGlasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal).Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfOsimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer.Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer.

Leave a Comment / Uncategorized / admin

Post Content

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top